35H Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Homology Medicines Inc

Watchlist Manager

Watchlist

Price: 0.02 EUR Market Closed

Market Cap: €1.1m

H	Homology Medicines Inc XBER:35H	US
	Revenio Group Oyj F:R0V	FI
M	Murphy Usa Inc F:1MU	US
	Goldstar Minerals Inc F:2OG0	CA
B	Biprogy Inc XMUN:NIU	JP
C	Carebook Technologies Inc OTC:CRBKF	CA
	China Telecom Corp Ltd F:ZCH	CN
	Pepper Money Ltd ASX:PPM	AU

Profitability Summary

Homology Medicines Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

31%

Negative 3Y Average Operating Margin

-8.283%

Operating Margin is Increasing

-3.849% > 31%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-8.995%

Net Margin is Increasing

-3.936% > 55%

Negative Free Cash Flow Margin

-62%

Negative 3Y Average Free Cash Flow Margin

-8.338%

Free Cash Flow Margin is Increasing

-3.419% > -62%

Exceptional ROE

125%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-392%

ROIC is Increasing

-276% > 141%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.